Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 19.04 Billion | USD 39.35 Billion | 8.4% | 2023 |
The global Digital Diabetes Management market size was worth around USD 19.04 billion in 2023 and is predicted to grow to around USD 39.35 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.4% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the Digital Diabetes Management market on a global and regional level.
Artificial intelligence (AI), digital research, and digital medicine allow continuous and remote monitoring of patients’ symptoms, behaviors, and physiological data via wearable devices, smartphone applications, and sensors. Diabetes treatment relies hugely on comprehensive data. Digital diabetes management solutions offer continuous blood glucose monitoring apart from keeping track of the values. Thus, these digital diabetes management solutions are gaining momentum worldwide.
Diabetes prevalence is growing rapidly due to a sedentary lifestyle and changing dietary habits. As per the World Health Organization, about 1.6 million deaths were directly associated with diabetes in 2016. As per the International Diabetes Federation estimates, about 425 million adults had diabetes worldwide in 2017, which is expected to reach about 629 million by 2045. Approximately, USD 727 billion was spent on adult health due to diabetes. Diabetes poses a major challenge to the society and thus healthcare companies are focusing to offer technologically advanced solutions to control diabetes worldwide.
The increasing prevalence of diabetes worldwide, rising geriatric population base, and growing penetration of smart devices, digital platform, and adoption of mobile apps are likely to fuel the global digital diabetes management market in the future. Additionally, technological advancements and the growing adoption of digital solutions worldwide are projected to further propel this market’s growth over the estimated timeframe. Other factors that are anticipated contribute toward the growth of the digital diabetes management market are increasing health awareness and expenditure and digitalization of healthcare systems. However, the high cost of digital devices and lack of reimbursement policies in emerging countries may hamper the digital diabetes management market globally.
The study provides a decisive view of the digital diabetes management market by segmenting the market based on type, product and service, end-user, and region.
By type, the market is segmented into wearable and handheld devices.
By product and service, the market is segmented into devices, digital diabetes management apps, data management software and platforms, and services.
The devices segment is sub-segmented into continuous glucose monitoring systems, smart glucose meters, smart insulin pens, and closed-loop systems/smart insulin pumps and smart insulin patches. The digital diabetes management apps are sub-classified into diabetes and blood glucose tracking apps and weight and diet management apps.
By end-user, the market is segmented into individuals/home healthcare, academic and research institutes, hospitals and specialty diabetes clinics, and others.
Report Attributes | Report Details |
---|---|
Report Name | Digital Diabetes Management Market |
Market Size in 2023 | USD 19.04 Billion |
Market Forecast in 2032 | USD 39.35 Billion |
Growth Rate | CAGR of 8.4% |
Number of Pages | 110 |
Key Companies Covered | Medtronic, Dexcom, B. Braun, Abbott Laboratories, Tandem Diabetes Care, Insulet Corporation, Lifescan Inc., Ascensia Diabetes Care, AgaMatrix, Glooko Inc., Tidepool, and Dariohealth, among others |
Segments Covered | By type, By product and service, By end-user and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.
By region, North America dominated the global digital diabetes management market with a revenue share of about 40% in 2023. This can be due to the increasing prevalence of diabetes, growing digital platform penetration, and favorable reimbursement policies by the government. North America is estimated to lead over the forecast time period, owing to the technological advancements and growing adoption of smart devices. Europe is the second largest region in the global digital diabetes management market, owing to the increasing diabetic population, government initiatives to control diabetes and obesity, and rising healthcare expenditure. Asia Pacific is projected to show the highest CAGR over the forecast time period in the global digital diabetes management market, owing to increasing geriatric population, rising diabetes prevalence, and growing awareness, healthcare expenditure, and adoption of digital platforms.
Some key players of the global digital diabetes management market include:
Global Digital Diabetes Management Market: By Type
Global Digital Diabetes Management Market: By Product and Service
Global Digital Diabetes Management Market: By End-User
Global Digital Diabetes Management Market: By Region
FrequentlyAsked Questions
Digital diabetes management refers to the use of digital tools and technologies to monitor, manage, and support individuals with diabetes.
According to study, the Digital Diabetes Management market size was worth around USD 19.04 billion in 2023 and is predicted to grow to around USD 39.35 billion by 2032.
The CAGR value of Digital Diabetes Management market is expected to be around 8.4% during 2024-2032.
North America has been leading the Digital Diabetes Management market and is anticipated to continue on the dominant position in the years to come.
The Digital Diabetes Management market is led by players like Medtronic, Dexcom, B. Braun, Abbott Laboratories, Tandem Diabetes Care, Insulet Corporation, Lifescan Inc., Ascensia Diabetes Care, AgaMatrix, Glooko Inc., Tidepool, and Dariohealth, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed